Cresco Labs Inc. (CRLBF) delivered earnings and revenue surprises of 0% and 2.26%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Revenue: $724 million for the full year 2024, a 6% decline year-over-year.Adjusted Gross Profit: Held flat year-over-year despite revenue decline.Adjusted EBIT
Mar 12, 2025 / 12:30PM GMTOperator Hello everyone and thank you for standing by. Today's call will be beginning momentarily. We thank you for your patience. Goo
Record full year operating cashflow of $132 million, an increase of 126% from the prior year period Record full year operating cashflow of $132 million, an increas…
Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (”Cresco Labs” or the ”Company”), the industry leader in branded cannabis products with a portfoli
On December 31, 2022, Eminence Capital, LP, a prominent investment firm, executed a significant transaction by acquiring 17,753,792 shares of Cresco Labs Inc. T